INTERNATIONAL PATENT: THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL FILES APPLICATION FOR "COMPOUNDS FOR USE IN A METHOD OF TARGETED PROTEIN DEGRADATION"

GENEVA, Feb. 3 -- THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (123 Old Brompton RoadLondon SW7 3RP) filed a patent application (PCT/GB2024/051886) for "COMPOUNDS FOR USE IN A METHOD OF TARGETED PROTEIN DEGRADATION" on Jul 18, 2024. With publication no. WO/2025/022093, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BELLENIE, Benjamin (c/o The Institute Of Cancer Research: Royal Cancer Hospital123 Old Brompton RoadLondon Greater London SW7 3RP), BRENNAN, Alfie (c/o The Institute Of Cancer Research: Royal Cancer...